Reports / Neurology Reports
With a specific focus on the Multiple Sclerosis (MS) market in the US and the EU, Spherix is shedding light on the key dynamic issues in this fast moving category. The increased risk tolerance and the expanding number of therapies in multiple sclerosis is evolving the treatment strategies for all forms of MS.
Rapid turnaround monitor for highly dynamic healthcare segments
Retrospective analysis of 1,000 +/- patient charts
Learn more about our work in the neurology space.